WHO’s approval for Covaxin likely this month
The Hindu
Covaxin is one of the six vaccines that have received emergency use authorisation from India’s drug regulator
The World Health Organization’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come this month, official sources said on Monday. The WHO has so far approved COVID vaccines developed by Pfizer-BioNTech, U.S. pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use. Covaxin is one of the six vaccines that have received emergency use authorisation from India’s drug regulator and is being used in the nationwide inoculation programme, alongwith Covishield and Sputnik V.More Related News
The 29th edition of the Conference of Parties (COP29), held at Baku in Azerbaijan, is arguably the most important of the United Nations’ climate conferences. It was supposed to conclude on November 22, after nearly 11 days of negotiations and the whole purpose was for the world to take a collective step forward in addressing rising carbon emissions.